Latest news with #430.00
Business Insider
28-06-2025
- Business
- Business Insider
Nuvama Remains a Buy on Aurobindo Pharma Ltd (AUROPHARMA)
In a report released yesterday, Shrikant Akolkar from Nuvama maintained a Buy rating on Aurobindo Pharma Ltd (AUROPHARMA – Research Report), with a price target of INR1,460.00. The company's shares closed yesterday at INR1,121.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Akolkar is a 2-star analyst with an average return of -2.3% and a 0.00% success rate. Akolkar covers the Healthcare sector, focusing on stocks such as Aurobindo Pharma Ltd, Cipla Ltd, and Jubilant Pharmova Limited. Currently, the analyst consensus on Aurobindo Pharma Ltd is a Moderate Buy with an average price target of INR1,430.00. Based on Aurobindo Pharma Ltd's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of INR83.82 billion and a net profit of INR9.03 billion. In comparison, last year the company earned a revenue of INR75.8 billion and had a net profit of INR9.09 billion
Business Insider
28-06-2025
- Business
- Business Insider
Citi Remains a Sell on Tech Mahindra Limited (TECHM)
Citi analyst Surendra Goyal maintained a Sell rating on Tech Mahindra Limited (TECHM – Research Report) yesterday and set a price target of INR1,430.00. The company's shares closed yesterday at INR1,674.40. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Goyal covers the Technology sector, focusing on stocks such as LTIMindtree Limited, Tech Mahindra Limited, and HCL Technologies Limited. According to TipRanks, Goyal has an average return of 0.7% and a 60.00% success rate on recommended stocks. The word on The Street in general, suggests a Hold analyst consensus rating for Tech Mahindra Limited with a INR1,509.15 average price target, which is a -9.87% downside from current levels. In a report released on June 19, Morgan Stanley also downgraded the stock to a Sell with a INR1,575.00 price target.
Business Insider
01-06-2025
- Business
- Business Insider
Alkem Laboratories Ltd. (ALKEM) Receives a Buy from Nomura
Nomura analyst Saion Mukherjee maintained a Buy rating on Alkem Laboratories Ltd. (ALKEM – Research Report) yesterday and set a price target of INR5,430.00. The company's shares closed last Friday at INR5,098.50. Confident Investing Starts Here: Mukherjee covers the Healthcare sector, focusing on stocks such as Alkem Laboratories Ltd., Cipla Ltd, and Fortis Healthcare Ltd.. According to TipRanks, Mukherjee has an average return of 12.5% and a 35.71% success rate on recommended stocks. In addition to Nomura, Alkem Laboratories Ltd. also received a Buy from ICICI Securities's Abdulkader Puranwala in a report issued on May 30. However, on the same day, J.P. Morgan maintained a Hold rating on Alkem Laboratories Ltd. (NSE: ALKEM). The company has a one-year high of INR6,440.00 and a one-year low of INR4,409.90. Currently, Alkem Laboratories Ltd. has an average volume of 2,117.
